Determinants of antepartum human immunodeficiency virus testing in a non-Medicaid obstetric population. by Cardonick, E et al.
Thomas Jefferson University
Jefferson Digital Commons
Department of Obstetrics and Gynecology Faculty
Papers Department of Obstetrics and Gynecology
1-1-1998
Determinants of antepartum human
immunodeficiency virus testing in a non-Medicaid
obstetric population.
E Cardonick
Thomas Jefferson University
S Daly
Thomas Jefferson University
M Dooley
Thomas Jefferson University
K Elles
Thomas Jefferson University
N S Silverman
Thomas Jefferson University
Let us know how access to this document benefits you
Follow this and additional works at: http://jdc.jefferson.edu/obgynfp
Part of the Obstetrics and Gynecology Commons
This Article is brought to you for free and open access by the Jefferson Digital Commons. The Jefferson Digital Commons is a service of Thomas
Jefferson University's Center for Teaching and Learning (CTL). The Commons is a showcase for Jefferson books and journals, peer-reviewed scholarly
publications, unique historical collections from the University archives, and teaching tools. The Jefferson Digital Commons allows researchers and
interested readers anywhere in the world to learn about and keep up to date with Jefferson scholarship. This article has been accepted for inclusion in
Department of Obstetrics and Gynecology Faculty Papers by an authorized administrator of the Jefferson Digital Commons. For more information,
please contact: JeffersonDigitalCommons@jefferson.edu.
Recommended Citation
Cardonick, E; Daly, S; Dooley, M; Elles, K; and Silverman, N S, "Determinants of antepartum
human immunodeficiency virus testing in a non-Medicaid obstetric population." (1998). Department
of Obstetrics and Gynecology Faculty Papers. Paper 24.
http://jdc.jefferson.edu/obgynfp/24
Infectious Diseases in Obstetrics and Gynecology 6:209-213 (1998)
(C) 1998 Wiley-Liss, Inc.
Determinants of Antepartum Human
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Obstetric Population
E. Cardonick,* S. Daly, M. Dooley, K. Elles, and N.S. Silverman
Department of Obstetrics and Gyn’ecology, Jefferson Medical College of Thomas Jefferson University,
Philadelphia, PA
ABSTRACT
Objective: To determine voluntary human immunodeficiency virus (HIV) testing rates and factors
influencing testing in a private obstetric practice.
Methods: Antepartum patients were offered HIV testing after completing a self-assessment ques-
tionnaire. Perceived risks and demdgraphics were correlated with testing rates.
Results: Overall, 348/600 (58%) women consented to HIV testing. In a univariate analysis,
patients with "any" perceived risk(s) were more likely to be tested. Single women and those with
an at-risk partner(s) or a history of sexually transmitted disease (STD) were more likely to desire
testing. These factors remained independently associated with voluntary testing in a multivariate
regression model. No patients tested positive for HIV.
Conclusions: In our private obstetric practice, 26% of women perceived themselves at risk for
HIV infection, and testing rates depended on the various risks identified. A history of STDs or an
at-risk sexual partner were stronger predictors of voluntary testing than was marital status. Fo-
cused HIV counseling among pregnant women at relatively low risk for infection may be possible.
Infect. Dis. Obstet. Gynecol. 6:209-213, 1998. (C) 1998 Wiley-Liss, Inc.
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nfection with the human immunodeficiency virus
(HIV) is now the fourth leading cause of death for
women of reproductive age in the United States
and is an increasingly important cause of morbidity
and mortality for their children. Neonatal HIV in-
fection and acquired immunodeficiency syndrome
(AIDS) are attributable to maternal infection and
vertical transmission in over 90% of cases,z Despite
comprising the largest growing group of newly in-
fected individuals, women, particularly those in mi-
nority groups, may not fully benefit from HIV edu-
cation and testing programs. In 1991, the National
Health Interview Survey NHIS-AIDS reported
that only 18.8% of reproductive-aged women (ages
18-44 in United States households) reported hav-
ing been HIV tested.3
Controlled trials have demonstrated that the
treatment of HIV-infected women during preg-
nancy with antiretroviral agents, such as zidovu-
dine (AZT), can dramatically lower the risk of ma-
ternal-neonatal HIV transmission.4,5 We have re-
cently demonstrated that knowledge about such
therapies is limited among inner-city women at
high risk for HIV infection, though the availability
of medicine to lower the risk of vertical HIV trans-
mission, even in the absence of clear maternal ben-
efit, was viewed almost uniformly by these women
as both important and acceptable.6 Comprehensive
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TABLE I. Patient questionnaire
I. Have you ever had a blood transfusion?
If yes, was it before or after 1985?
2. Have you ever been treated for a sexually transmitted disease?
(gonorrhea, chlamydia, syphilis)
3. Have you ever used street drugs by injection (shooting up)?
4. Have you had sexual relations with a partner who ever had a blood transfusion?
5. Have you had sexual relations with a partner who ever used drugs by injection?
6. Have you had sexual relations with a man who ever had sex with other men?
7. Have you ever had sexual relations with a partner who might have been at high risk for HIV?
8. Do you think that you are at risk at all for being HIV-infected?
Please check one of the following:
would like to be HIV tested.
need to think more about HIV testing.
do not want to be HIV tested.
would like to meet formally with an HIV educator before deciding.
have chosen not to fill out this questionnaire.
Signature
Yes
Before
Yes
No
After
No
Yes No
Yes No
Yes No
Yes No
Yes No
Yes No
Date
Don’t know
Don’t know
Don’t know
Don’t know
HIV counseling and testing in at-risk populations
are essential for overall risk assessment, for tar-
geted patient education directed toward risk reduc-
tion and behavior modification, and for the early
identification and treatment of newly infected in-
dividuals and their partners. The obstetrician’s and
pediatrician’s ability to reduce mother-to-child
HIV transmission depends on antepartum knowl-
edge of a mother’s serostatus.
The issues of pregnancy-related HIV counseling
and testing have been addressed in indigent, inner-
city populations; however, few studies have ad-
dressed screening and its acceptance in presumably
low-risk populations. Therefore, we designed this
study in the context of instituting a policy of offer-
ing HIV testing to all patients within a city-based,
non-Medicaid, private practice population. We
asked all patients registering for obstetric care to
self-assess their HIV risks by means of a checklist
questionnaire, then offered HIV testing to them
all. We planned to evaluate the acceptance of HIV
testing and to assess the degree of perceived risk.
We additionally hoped to identify risk factors in the
specific patient population that were most directly
associated with a voluntary decision to undergo
HIV testing. Until these issues are better under-
stood, calls for global public health policies will
continue to be based on presumption rather than
on documented results.
SUBJECTS AND METHODS
Patients were recruited from three private obstetric
practices whose patients delivered at a common
university hospital. Ninety percent of patients
were privately insured. Racial/ethnic demographics
of the study population were as follows: 70% Cau-
casian, 19% African American, 4% Asian, 2% His-
panic or Indian, and 5% for whom information was
unreported. Between January 1996 and January
1997, all patients registering for prenatal care were
asked to complete a yes-or-no questionnaire that
outlined their social and demographic backgrounds
in the context of HIV infection risks (Table 1). A
cover letter accompanied each questionnaire ex-
plaining the project and emphasizing that both
completing the survey and consenting to HIV test-
ing were voluntary and in no way linked to the
provision of prenatal care. All patients subse-
quently discussed HIV counseling in light of the
results of their individual survey with their physi-
cian or nurse practitioner, and HIV testing was
then offered to each patient. A separate formal ses-
sion with an HIV counselor was made available to
all patients.
The incidence of individual HIV risk factors was
calculated for the population as a whole with com-
parison of HIV testing acceptance rates made be-
tween those with risks and those without them.
Comparisons of risk factors as well as testing rates
were also made with regards to marital status. Non-
continuous data were analyzed with a corrected
chi-square and Fisher exact test; pooled two-tailed
Student t tests were employed for continuous data.
Univariate as well as logistic regression analyses
were employed to determine the sociodemographic
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TABLE 2. HIV testing in pregnancy: risk factor
results
Any risk for HIV % of all patients
infection (n 153) N with risks
History of STD 106 69%
Partner risk 24 16%
History of blood transfusion 23 15%
Occupational risk 12 7.8%
History of intravenous drug use 0.6%
aResults add up to > 100% due to patients with multiple risk factors for
HIV.
characteristics most associated with acceptance of
HIV testing. Statistical significance was accepted at
a P value < 0.05.
RESULTS
Six hundred women registering for prenatal care
completed the questionnaire; only three patients
who were approached for participation chose not to
complete the survey. The mean age of women in
the study group was 30.5 _+ 5.5 years; 77% of the
women were married. Of the 600 women surveyed,
348 patients consented to HIV testing (58%), with
no positive HIV test results identified during the
12-month study period.
Rates of reporting risk factors for HIV infection,
abstracted from responses to the questionnaire, are
listed in Table 2. As shown, 153 (26%) of the 600
women surveyed in this study identified behaviors
or risks that could place them at risk for HIV in-
fection. The risks most commonly identified in this
survey were: (1) history of a sexually transmitted
disease (STD), (2) an at-risk partner, or (3) a history
of blood transfusion.
The relationship of the women’s marital status
to both the presence of HIV risk factors and to
voluntary testing rates is analyzed in Table 3.
Single or divorced women were more likely to
identify factors associated with an increased risk of
HIV infection, particularly a history of STD, and
were also more likely than married women to un-
dergo HIV testing (68% vs. 55%; P .006).
In a univariate analysis, outlined in Table 4, pa-
tients with any perceived risk for HIV infection
were more likely to undergo voluntary testing than
those without self-perceived risks. Specifically, we
found that women with a history of STD, occupa-
tional exposure, or an at-risk sexual partner(s) were
TABLE 3. Association of marital status and HIV risk
factors
Marital status
Single/
Married Divorced
(n 461) (n 139) P value
Any risk for HIV 94 (20%) 58 (42%) <.0001
History of STD 59 (13%) 46 (33%) <.000
Partner risk
Yes 16 (3.5%) 8 (6%) NS
Don’t know 69 (I 5%) 21 (I 5%)
Tested for HIV 253 (55%) 95 (68%) .006
aNS not significant.
TABLE 4. Results: risk factors and their impact on
HIV testing
Tested
No Yes % P
Any perceived risk factor
Yes (n 153) 39 114 75
No (n 447) 215 232 52 .001
Specific risk factor
I. History of sexually transmitted disease
Yes (n 106) 23 83 78
No (n 494) 229 265 54 .001
2. History of blood transfusion
Yes (n 23) 10 13 57
No (n 577) 242 335 58 NS
3. History of intravenous drug use
Yes (n I) 0 0
No (n 599) 251 348 58 NS
4. Occupational risk
Yes (n 12) 92
No (n 588) 251 337 57 .02
5. Sexual relations with a partner at risk
Yes (n 24) 5 19 79
No (n 486) 225 261 54
Don’t know (n 90) 22 68 75 .001
more likely to be tested for HIV. Women with oc-
cupational exposure to HIV, though their absolute
number was small, had the highest rate of accept-
ing HIV testing (92%) among any of the identified
at-risk subgroups. Overall, just over half of women
without self-perceived risk for HIV infection un-
derwent voluntary testing, while only 25% of
women acknowledging risk factors or behaviors as-
sociated with infection chose not to be tested. The
results of a multivariate regression analysis factor-
ing risk factors, age, and marital status into the as-
sessment of determinants of voluntary HIV testing
revealed that partner risk, occupational exposure,
STD history, and marital status remained signifi-
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cantly associated with a decision to undergo HIV
testing.
DISCUSSION
Infection with HIV is an increasing cause of illness
and death among women, while perinatally ac-
quired HIV infection in children of women with
HIV accounts for the greatest majority of pedia-
tric AIDS cases,z,7 Pregnancy may be the only op-
portunity for medical care for at-risk patients.
Modifications of routine obstetric practice aimed to
decrease neonatal transmission in addition to ma-
ternal and neonatal AZT rely on the early identi-
fication of HIV-infected pregnant women.
Pregnancy may provide an impetus for testing
among women who would otherwise decline it. As-
sessment of the acceptability of HIV testing for all
women, and not just for those in risk groups, is
critical for the development of effective testing
policies. Irwin et al. evaluated all published studies
of HIV testing rates in a variety of at-risk popula-
tions. Factors most associated with voluntary HIV
testing included the patients’ perception of HIV
risk, acknowledgment of risk behaviors, confiden-
tiality protection, presenting counseling and test-
ing as "routine" rather than optional, and the pro-
viders’ belief that HIV testing would benefit the
patient.8
Antenatal HIV screening policies are extremely
variable across the United States. While mandatory
testing would have the advantage of identifying all
HIV-positive women when they are seeking care,
this policy compromises individual autonomy, pre-
cludes informed consent, and may discourage high-
est-risk patients from seeking prenatal care be-
cause of fears of either discrimination or denial of
health care benefits. A testing method that de-
pends solely on a clinician-patient discussion, par-
ticularly at the first medical visit, may not allow
assessment of a woman’s true risk, as she may be
unwilling to disclose sexual history, drug use, or
other behaviors that may be seen as socially unac-
ceptable or stigmatizing. In fact, researchers have
shown that, in nonpregnant indigent populations,
selective testing based solely on HIV risk factors
identified through one-on-one interviewing failed
to identify over 50% of seropositive women.9-1z A
prior report from our institution further demon-
strated that physically removing the HIV counsel-
ing and testing process from the medical care sec-
tion of a prenatal clinic significantly increased the
patients’ acceptance of HIV testing. 13
The present study was designed to address both
the limitations of the previously cited strategies for
prenatal HIV testing and the changing nature of
HIV infection in women, as heterosexual transmis-
sion is increasingly responsible for newly acquired
cases. We designed a universally-offered, self-
administered questionnaire to be completed by
women in a presumably lower-risk setting for HIV
infection, i.e., a city-based, non-Medicaid obstetric
population. This particular population has tradi-
tionally not been widely studied in HIV epidemi-
ology. Attitudes among these women about their
own risk for HIV infection, and their acceptance of
HIV testing in general, along with identification of
demographic factors associated with a decision to
undergo testing, needs to be appropriately evalu-
ated. This population may be perceived as "low
risk" for HIV infection due to a low prevalence of
intravenous drug use; however, heterosexual expo-
sure and occupational risk may be other important
HIV risk factors for this particular population. We
hoped that the nature of the questionnaire would
allow nonconfrontational self-assessment for each
woman, along with an introduction to or reinforce-
ment of information about behaviors associated
with a risk of HIV infection.
Our study is the largest conducted to date in this
type of prenatal population and demonstrates that
acceptance of the risk assessment questionnaire
among non-indigent pregnant women was almost
universal, although over 40% ofwomen completing
the survey subsequently declined HIV testing. Ap-
proximately one quarter of the women surveyed
acknowledged risks for HIV infection, with testing
rates significantly higher within this subgroup
(75%). Among women without self-identified risk
factors, the testing rate was still 52%. Even after
controlling for interactions in a multivariate analy-
sis, an STD history for a woman or her partner
remained significantly and independently associ-
ated with a decision to undergo HIV testing, as did
marital status of single or divorced.
Studies conducted in inner-city indigent obstet-
ric settings show testing rates as high as 90%. 11,13,14
In contrast low voluntary testing rates (less than
25%) in private obstetric populations have been
reported. 1 In our private obstetric population,
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57-92% of patients accepted HIV testing, depend-
ing on the specific self-perceived risk factor iden-
tified.
In summary, our study offers some insight into
HIV risk assessment and testing decisions among
women in an obstetric setting traditionally per-
ceived as "low-risk" for HIV infection. First, evalu-
ation of HIV risk factors among these women was
almost universally accepted, though a decision to
undergo testing was significantly associated with a
woman’s perception or acknowledgment of HIV-
related risk factors. We acknowledge that the study
is limited by lack of HIV seroprevalence data
among the women who declined testing; this sub-
group may have underestimated their risk or
wished to simply avoid testing due to increased but
concealed risk for infection. It is also notable that,
among the 348 women tested during the study pe-
riod, none were HIV positive. This questionnaire
has since been incorporated into the routine pa-
tient management framework of the participating
practices. One asymptomatic individual who de-
nied risk factors yet consented to HIV testing dur-
ing pregnancy was found to be seropositive. The
experience of this individual patient, while anec-
dotal, illustrates the need for incorporating HIV
education and testing protocols into all obstetric
populations and not limiting efforts to historically
high-risk patients.
It is hoped that studies like this one will begin
to fill gaps in our approach to providing care and
options to all women of reproductive age, in a for-
mat that is neither confrontational nor stigmatizing.
With demonstrated rates for acceptance of HIV
testing that are substantially higher than those re-
ported in other low-risk obstetric settings, our
study represents an approach that has shown value
for further investigation and refinement. Because
there are patients who deny risk factors yet desire
HIV testing, because physician-patient interviews
may not accurately disclose risk factors, and be-
cause some women may not be aware that they
have an at-risk heterosexual partner, we encourage
universal counseling and voluntary testing for all
pregnant women.
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